Key Publications and Posters

Publications and Posters

Related to KEVEYIS^® (dichlorphenamide)
Related to Macrilen^TM (macimorelin)
Related to Investigational Agent RECORLEV^TM (levoketoconazole)*
- About Cushing’s Syndrome
- Current Management of Cushing’s Syndrome
- Health and Economic Burden From Cushing’s Syndrome
- Levoketoconazole-specific – RECORLEV (levoketoconazole)
- Levoketoconazole-specific – Articles Related to Diobex Development of DIO-902 (development program for treatment of diabetes no longer active)
Related to Investigational Agent Veldoreotide*

* Investigational product candidates. The safety and efficacy of RECORLEV (levoketoconazole) and veldoreotide have not been established. Please see KEVEYIS Important Safety Information and Full Prescribing Information. Please see Macrilen Important Safety Information and Full Prescribing Information.

© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA^® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS^® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
Macrilen^™ is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V14 08/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program